Uliledlimab
Product Specifications
CAS Number
2378407-27-1
Target
CD73, cAMP
Related Pathways
GPCR/G Protein, Immunology/Inflammation
Purity
0.955
Bioactivity
Uliledlimab is a humanized monoclonal antibody with potent inhibitory activity against CD73, the ecto-5'-nucleotidase enzyme that catalyzes the conversion of extracellular AMP to adenosine. Uliledlimab reduces extracellular adenosine production, thereby modulating immunosuppressive pathways. Uliledlimab holds significant potential for use in immuno-oncology and cancer research.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS566998-01 0.2 mg
Hapten 4-hydroxy-3-nitrophenyl acetyl NP Recombinant monoclonal antibody (B1-8) (Mouse IgG2c lambda)
Sign In for Pricing
View Details